Physician

Abdul Qadir, M.D.

According to 2025 Medicare claims, Abdul Qadir, M.D. (NPI: 1699898619) practices nephrology in the Sandusky, OH market, with the plurality of this provider's patient population coming from Erie, OH. This provider's primary affiliated billing organization is NORTH COAST PROFESSIONAL COMPANY, LLC (NPI: 1881648210; TIN: 341608091) and primary practice location at 44870-3323. Qadir is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Qadir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 558 traditional Medicare patients, billed 3,146 HCPCS/CPT codes, and received $209,526 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,261 prescription claims across 421 beneficiaries totaling $163,734 in drug costs, led by Lokelma (Sodium Zirconium Cyclosilicate). 2022 DME data shows 56 claims. Open Payments data shows 6 records totaling $110. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $11,218 to $163,734. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	400	1,446	$131,223
2016	652	3,684	$290,788
2017	776	4,945	$384,435
2018	797	4,917	$379,206
2019	800	5,778	$401,579
2020	750	4,438	$369,391
2021	716	3,318	$387,031
2022	629	3,084	$291,293
2023	571	2,890	$247,207
2024	558	3,146	$209,526

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	107	278	$11,218
2016	260	1,101	$83,045
2017	341	1,380	$156,779
2018	416	1,880	$115,756
2019	442	1,943	$91,889
2020	445	2,029	$100,870
2021	447	1,895	$144,038
2022	474	2,179	$198,179
2023	445	2,175	$219,684
2024	421	2,261	$163,734

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$669
2021	N/R	N/R	N/R
2022	N/R	56	$1,399
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	67	191	$268
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	57	102	$227
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	121	152	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	340	570	$89
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	147	439	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lokelma	Sodium Zirconium Cyclosilicate	25	1,163	$27,048
Sevelamer Carbonate	Sevelamer Carbonate	104	6,882	$23,586
Calcium Acetate	Calcium Acetate	100	5,813	$7,678
Prosol	Parenteral Amino Acid 20% No.1	36	253	$4,394
Potassium Chloride	Potassium Chloride	100	8,039	$3,587

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$110	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul Qadir, M.D.?

Tedicare shows public-source Medicare data for Abdul Qadir, M.D. (NPI 1699898619), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Qadir, M.D. have ACO affiliation data?

Abdul Qadir, M.D. is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Abdul Qadir, M.D.?

Abdul Qadir, M.D. is linked to NORTH COAST PROFESSIONAL COMPANY, LLC (billing NPI 1881648210) in the available physician profile data.

Does Abdul Qadir, M.D. have Open Payments data?

Abdul Qadir, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.